A Meta-Analysis of Nucleos(t)ide Analogues in Patients with Decompensated Cirrhosis Due to Hepatitis B

被引：0
|
作者：
Yingnan Huang
Hao Wu
Shengdi Wu
Da Fu
Yushui Ma
Xizhong Shen
机构：
[1] Zhongshan Hospital of Fudan University,Department of Gastroenterology
来源：
Digestive Diseases and Sciences | 2013年 / 58卷
关键词：
Hepatitis B; Chronic; Liver cirrhosis; Decompensated; Nucleos(t)ide analogues;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：815 / 823
页数：8
相关论文
共 50 条
  • [41] Association of Serum Hepatitis B Virus RNA With Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Under Nucleos(t)ide Analogues Therapy
    Liu, Shi
    Deng, Rui
    Zhou, Bin
    Liang, Xieer
    Liu, Zhihong
    Peng, Jie
    Chen, Jinjun
    Zhou, Yuanping
    Guo, Yabing
    Chen, Yongpeng
    Li, Wanying
    Shen, Sheng
    Lu, Xingyu
    Zhao, Siru
    Liao, Xingmei
    Liang, Hongyan
    Lan, Yu
    Hou, Jinlin
    Fan, Rong
    Sun, Jian
    JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (05) : 881 - 890
  • [42] Real-world study on clinical outcomes of nucleos(t)ide analogues antiviral therapy in patients with chronic hepatitis B
    Sun, Y.
    Zhang, Y.
    Xu, Y.
    Shu, M.
    Bonroy, K.
    Qiu, H.
    Cai, W.
    EPIDEMIOLOGY AND INFECTION, 2019, 147
  • [43] Serum HBV RNA predicts HBeAg clearance and seroconversion in patients with chronic hepatitis B treated with nucleos(t)ide analogues
    Wang, Yang
    Liao, Hao
    Deng, Zhongping
    Liu, Yanna
    Bian, Dandan
    Ren, Yan
    Yu, Guangxin
    Jiang, Yingying
    Bai, Li
    Liu, Shuang
    Liu, Mei
    Zhou, Li
    Chen, Yu
    Duan, Zhongping
    Lu, Fengmin
    Zheng, Sujun
    JOURNAL OF VIRAL HEPATITIS, 2022, 29 (06) : 420 - 431
  • [44] HBeAg-negative chronic hepatitis B: why do I treat my patients with nucleos(t)ide analogues?
    Vigano, Mauro
    Mangia, Giampaolo
    Lampertico, Pietro
    LIVER INTERNATIONAL, 2014, 34 : 120 - 126
  • [45] Is it possible to stop nucleos(t)ide analogue treatment in chronic hepatitis B patients?
    Moreno-Cubero, Elia
    Sanchez del Arco, Robert T.
    Pena-Asensio, Julia
    Sanz de Villalobos, Eduardo
    Miquel, Joaquin
    Ramon Larrubia, Juan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (17) : 1825 - 1838
  • [46] Albumin-bilirubin score is associated with response to pegylated interferon and nucleos(t)ide analogues in chronic hepatitis B patients
    Xun, Zhen
    Liu, Can
    Yu, Qing-Qing
    Lin, Jin-Piao
    Huang, Jin-Lan
    Yang, Ting-Wen
    Wu, Wen-Nan
    Wu, Song-Hang
    Ou, Qi-Shui
    CLINICA CHIMICA ACTA, 2020, 502 : 120 - 127
  • [47] Effect of nucleos(t)ide analogues on blood lipid profiles in patients with chronic hepatitis B: A cross-sectional survey
    Chen, Jing Wen
    Cao, Xiong Yue
    Qi, Xun
    Zhang, Ji Ming
    MEDICINE, 2022, 101 (50) : E31980
  • [48] Effects of first-line nucleot(s)ide analogues on lipid profiles in patients with chronic hepatitis B: a network meta-analysis
    Tong, Kexin
    Chen, Mingjing
    Wang, Danni
    Dai, Haifeng
    Peng, Jiayi
    Zhang, Jia
    Zhou, Jiao
    Chang, Yujiao
    Huang, Wenxiang
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 80 (03) : 335 - 354
  • [49] Is it possible to stop nucleos(t)ide analogue treatment in chronic hepatitis B patients?
    Elia Moreno-Cubero
    Robert T Sánchez del Arco
    Julia Pe?a-Asensio
    Eduardo Sanz de Villalobos
    Joaquín Míquel
    Juan Ramón Larrubia
    World Journal of Gastroenterology, 2018, 24 (17) : 1825 - 1838
  • [50] Persistence profile to nucleos(t)ide analogue treatment for patients with chronic hepatitis B
    Borrego Izquierdo, Yolanda
    Gomez Fernandez, Encarnacion
    Monje Agudo, Patricia
    Jimenez Galan, Rocio
    Almeida-Gonzalez, Carmen V.
    Ferrit Martin, Monica
    Morillo Verdugo, Ramon
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2016, 23 (05) : 278 - 282
12345